instead they are known to have certain natural ingredients which the manufacturers claim to have similar effects as GLP-1 drugs 3
In other cases, a new formulation adapted for different administration routes, such as subcutaneous or oral administration, can be sufficient to obtain a new patent
If you inject 1 mg of semaglutide (half-life of approximately seven days), here is what happens
Dual GIP/GLP-1 agonists may be better for patients who havent achieved sufficient weight loss with GLP-1 medications alone, those requiring more aggressive metabolic intervention, individuals who can tolerate the slightly higher side effect rates at maximum doses, and patients seeking the most effective currently available FDA-approved option
With proper management like gradual dose increases and individualized care GLP-1 treatments can support meaningful, long-term weight loss while reducing the risk of side effects